$25.57
0.78% day before yesterday
NYSE, Dec 27, 10:00 pm CET
ISIN
US5004723038
Symbol
PHG

Royal Philips NV Sponsored ADR Stock price

$25.57
-1.58 5.82% 1M
-0.11 0.43% 6M
+3.01 13.35% YTD
+3.08 13.69% 1Y
-8.24 24.38% 3Y
-18.96 42.57% 5Y
-0.59 2.27% 10Y
NYSE, Closing price Fri, Dec 27 2024
-0.20 0.78%
ISIN
US5004723038
Symbol
PHG
Sector

Key metrics

Market capitalization $23.89b
Enterprise Value $30.85b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 20.72
EV/Sales (TTM) EV/Sales 1.57
P/S ratio (TTM) P/S ratio 1.22
P/B ratio (TTM) P/B ratio 1.88
Revenue growth (TTM) Revenue growth 2.16%
Revenue (TTM) Revenue $19.61b
EBIT (operating result TTM) EBIT $971.93m
Free Cash Flow (TTM) Free Cash Flow $1.49b
EPS (TTM) EPS $-0.49
P/E forward negative
P/S forward 1.22
EV/Sales forward 1.58
Short interest 0.12%
Show more

Is Royal Philips NV Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Royal Philips NV Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Royal Philips NV Sponsored ADR forecast:

5x Buy
31%
11x Hold
69%

Analyst Opinions

16 Analysts have issued a Royal Philips NV Sponsored ADR forecast:

Buy
31%
Hold
69%

Financial data from Royal Philips NV Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
19,607 19,607
2% 2%
100%
- Direct Costs 11,458 11,458
3% 3%
58%
8,148 8,148
2% 2%
42%
- Selling and Administrative Expenses 3,910 3,910
12% 12%
20%
- Research and Development Expense 1,878 1,878
15% 15%
10%
2,360 2,360
2% 2%
12%
- Depreciation and Amortization 1,388 1,388
12% 12%
7%
EBIT (Operating Income) EBIT 972 972
31% 31%
5%
Net Profit -455 -455
78% 78%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about Royal Philips NV Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Royal Philips NV Sponsored ADR Stock News

Neutral
Business Wire
3 days ago
SEOUL, South Korea--(BUSINESS WIRE)-- #CRI70--The German Federal Patent Court has confirmed the validity of Seoul Semiconductor's patents related to the CRI 70 technology.
Neutral
Business Wire
20 days ago
JACKSONVILLE, Fla.--(BUSINESS WIRE)--To help ensure more families have access to educational resources they need for healthy birth outcomes, the Northeast Florida Healthy Start Coalition (NEFHSC), Baptist Health and Philips Avent (NYSE: PHG, AEX: PHIA) have partnered to offer a one-year, no-cost subscription to the premium version of Philips' Pregnancy+. Pregnancy+, the number one pregnancy app...
Neutral
GlobeNewsWire
28 days ago
December 1, 2024 Philips CT 5300 combines innovative hardware, software, and artificial intelligence to make high-quality screening, diagnostic, and interventional imaging accessible to more patients, including reading support with Automated AI-enabled Philips Advanced Visualization Workspace applications Philips collaborates with Annalise.ai to evaluate streamlining workflows to prioritize tim...
More Royal Philips NV Sponsored ADR News

Company Profile

Royal Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and Other. The Personal Health segment focuses on healthy living and preventative care. This segment comprises the Personal Care, Domestic Appliances, Oral Healthcare, and Mother & Child Care businesses. The Diagnosis & Treatment segment unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. This segment comprises the Diagnostic Imaging, Ultrasound, Healthcare Informatics and Image-Guided Therapy businesses. The Connected Care & Health Informatics segment focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways and leveraging provider-payer-patient business models. This segment comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, and Sleep & Respiratory Care businesses. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Head office Netherlands
CEO Roy Jakobs
Employees 69,656
Founded 1891
Website www.usa.philips.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today